Provention Bio to Combine Forces with Sanofi to Support Potential U.S. Launch of Teplizumab for Delay in Onset of Clinical Type 1 Diabetes (T1D) in At-Risk Individuals – PR Newswire
Searching for your content… In-Language News Contact Us 888-776-0942 from 8 AM – 10 PM ET News provided byOct 06, 2022, 07:00 ETShare this articleRED BANK, N.J. , Oct. 6, 2022…